Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G for Structure Therapeutics Inc. Ordinary Shares, par value $0.0001 per share (GPCR).
- Disclosed ownership: 5.6%.
- Date of event: 11 Aug 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 5.6% ownership in Structure Therapeutics Inc. Ordinary Shares, par value $0.0001 per share (GPCR) on 11 Aug 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 2.9% | 4,986,351 | 0 | 4,986,351 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 2.9% | 4,986,351 | 0 | 4,986,351 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 2.3% | 3,902,022 | 0 | 3,902,022 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 2.3% | 3,902,022 | 0 | 3,902,022 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.3% | 530,763 | 0 | 530,763 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.3% | 530,763 | 0 | 530,763 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 5.1% | 8,888,373 | 0 | 8,888,373 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 5.6% | 9,611,751 | 0 | 9,611,751 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 5.6% | 9,611,751 | 0 | 9,611,751 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 5.6% | 9,611,751 | 0 | 9,611,751 | /s/ Mark N. Lampert | Mark N. Lampert |